The global medical foods market was valued at USD 26.52 Billion in 2025, driven by the rising prevalence of chronic diseases and growing awareness and demand for personalized nutrition in clinical settings across the globe. The market is anticipated to grow at a CAGR of 6.00% during the forecast period of 2026-2035, with the values likely to reach USD 47.49 Billion by 2035. The market is driven by increasing demand for condition-specific nutrition due to chronic illness prevalence and regulatory support for clinical nutrition. Growing clinical research and innovative product formulations are expected to boost market expansion in the forecast period.
Base Year
Historical Period
Forecast Period
According to Vijay Viswanathan et al., 2024, diabetic peripheral neuropathy (DPN) affects 18.8% to 61.9% of individuals with diabetes in India, significantly driving demand for medical foods targeted at neurological complications.
In May 2025, University of Florida researchers advocated the “Food Is Medicine” movement to combat obesity and diabetes. Such initiatives are expected to accelerate the medical foods market growth by increasing demand for nutrition-based therapies.
The growing demand for condition-specific nutrition is driving the medical foods market, with key players accelerating innovation and clinical research, significantly contributing to market growth through targeted product development and strategic expansions.
Compound Annual Growth Rate
6%
Value in USD Billion
2026-2035
*this image is indicative*
Medical foods play a vital role in managing chronic and metabolic disorders by providing targeted nutritional support under medical supervision. They are used in the treatment of conditions such as Alzheimer’s disease, chronic kidney disease, and diabetes, where standard diets are insufficient to meet specific nutritional needs. The market is experiencing steady growth and poised to grow at a CAGR of 6.00% during the forecast period of 2026–2035, due to increasing disease burden, rising healthcare awareness, and advancements in clinical nutrition. Expanding geriatric populations and evolving regulatory frameworks also contribute to market expansion.
Rising Chronic Kidney Disease Burden to Accelerate Market Growth
The growing incidence of chronic kidney disease (CKD) is a major factor fueling the expansion of the market. According to Anna Francis et al., April 2024, while years of life lost (YLL) due to major non-communicable diseases like stroke and heart disease are expected to decline by 2040, YLL from CKD are projected to rise significantly and surpass diabetes . This alarming trend is likely to increase the need for condition-specific nutritional support, thereby propelling market growth in the coming years.
Some of the notable trends in the market are the rising emphasis on high-protein formulations, supported by increasing regulatory backing and advancements in scientific research.
Emphasis on High-Protein Formulations to Boost Market Growth
The increasing prevalence of malnutrition among the elderly and chronically ill patients has driven demand for advanced, high-protein medical nutrition solutions globally. As a response to this growing need, companies are investing in innovative ingredients that improve patient compliance and nutritional outcomes. For example, in April 2025, Arla Foods Ingredients introduced Lacprodan MicelPure® Medical, an upgraded micellar casein isolate (MCI) designed for medical nutrition. The product addresses key challenges such as poor taste, unpleasant texture, and low viscosity, which often hinder pat ients from completing nutritional regimens. With improved microbiological quality and formulation versatility, this launch reflects a broader industry trend toward functionality-driven innovation. As high-protein, palatable solutions become integral to patient care, the medical foods market is projected to grow steadily, supported by rising demand and product development.
Rising Initiatives Intended for Regulatory Backing and Scientific Research to Strengthen Medical Foods Market Value
The market is witnessing a shift toward more transparent, science-based development, fueled by increasing regulatory involvement and rigorous nutritional research. In May 2025, the U.S. Food and Drug Administration (FDA), in collaboration with the National Institutes of Health (NIH), launched the Nutrition Regulatory Science Program . This initiative focuses on the health effects of ultra-processed foods, additives, and early-life nutrition, aiming to inform evidence-based policies and improve product formulation standards. By strengthening the scientific foundation for medical nutrition, such efforts are expected to build consumer trust and industry accountability. As a result, this growing regulatory-scientific synergy is poised to accelerate the global medical foods market growth in the years ahead.
Nutritional Deficiency to Lead the Market Segmentation Based on Application
Applications of medical foods span across a broad range of conditions, including chronic kidney disease, minimal hepatic encephalopathy, chemotherapy-induced diarrhea, pathogen-related infections, diabetic neuropathy, attention deficit hyperactivity disorder (ADHD), depression, Alzheimer’s disease, nutritional deficiency, orphan diseases, wound healing, chronic diarrhea, pain management, and others. Among these, the nutritional deficiency segment is poised to lead the market. The rising burden of global hunger and malnutrition has made this segment increasingly vital. According to the World Health Organization (WHO), around 733 million people, equivalent to one in eleven globally and one in five in Africa, faced hunger in 2023, as reported in the latest State of Food Security and Nutrition in the World (SOFI) report . This alarming trend underscores the growing demand for medical foods specifically formulated to combat nutritional deficiencies, thereby propelling growth in this application segment.
The regions included in the report are North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Among these, North America leads the market, driven by robust healthcare infrastructure, heightened health awareness, and a high burden of chronic diseases. For example, in March 2025, the Rockefeller Foundation and the U.S. Department of Veterans Affairs expanded their “Food is Medicine” initiatives across Texas, New York, North Carolina, Maryland, and Utah. These programs aim to enhance nutritional support and reduce diet-related illnesses among over 2,000 U.S. Veterans, further accelerating regional market growth.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Danone S.A. is a global leader in medical nutrition, offering specialized products designed to support patients with disease-related malnutrition, inborn errors of metabolism, and conditions such as dysphagia and epilepsy. Through its research & innovation division, Danone develops evidence-based medical foods tailored to specific health conditions and age groups. The company is deeply committed to integrating medical nutrition into healthcare, aiming to improve patient outcomes, reduce complications, and enhance quality of life.
Nestlé S.A. is a key player in the medical foods market, offering a wide portfolio of specialized nutritional products under its Medical Nutrition division. The company addresses diverse health needs through innovative products such as Peptamen® for gastrointestinal disorders, Gerber® Extensive HA® for cow’s milk protein allergy, BOOST® for healthy aging and diabetes, and Vitaflo® for inherited metabolic disorders. Nestlé collaborates with healthcare professionals and researchers to develop clinically backed solutions that support patients from infancy through adulthood, reinforcing its strong commitment to evidence-based, condition-specific nutrition.
Abbott, a global healthcare leader, actively contributes to the medical foods market through its innovative Healthy Food Rx program. This initiative, targeting individuals with diabetes, provides home-delivered, nutritious food boxes and educational resources. In June 2025, clinical trial findings presented at the American Diabetes Association's 2025 Scientific Sessions demonstrated that the program significantly improved diet quality and self-reported health status, reinforcing Abbott’s role in integrating nutrition with chronic disease management.
Fresenius Kabi AG is a healthcare company dedicated to improving patient care through specialized medical nutrition solutions. With over six decades of expertise, the company offers a wide range of products in the Global Medical Foods Market, including enteral and parenteral nutrition, oral nutritional supplements, and keto analogues. Key offerings such as Supportan® Drink, Fresubin® YOcrème, and Fresubin® Plant-Based Drink address malnutrition among vulnerable patient populations, including those with cancer , dysphagia, or increased energy needs. Fresenius Kabi’s continued innovation and patient-focused approach underscore its critical role in advancing nutritional therapy worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Primus Pharmaceuticals Inc., Reckitt Benckiser Group plc, and others.
"Medical Foods Market Report and Forecast 2026-2035" offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
Market Breakup by Route of Administration
Market Breakup by Application
Market Breakup by Sales Channel
Market Breakup by Region
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Administration |
|
| Breakup by Application |
|
| Breakup by Sales Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share